Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results
- PMID: 19890631
- DOI: 10.1007/s00259-009-1292-9
Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results
Abstract
Purpose: Major depressive disorder (MDD) has been related to both a dysfunctional gamma-amino butyric acid (GABA) system and to hyperactivity of the hypothalamic-pituitary-adrenal axis (HPA). Although GABA has been suggested to inhibit HPA axis activity, their relationship has never been studied at the level of the central GABA(A)-benzodiazepine receptor in depressed patients or in relation to antidepressant treatment.
Methods: Eleven depressed outpatients were compared, before and after treatment with citalopram, with nine age-matched healthy controls. The subjects were scanned using the positron emission tomography (PET) tracer [(11)C]flumazenil ([(11)C]FMZ). Parametric voxel-by-voxel Logan plots were compared with methods based on regions of interest (ROI), to provide volume of distribution (V(T)) and binding potential (BP(ND)) values. Plasma GABA levels were determined and a dexamethasone-corticotropin releasing hormone (DEX-CRH) test was performed.
Results: In MDD, parametric voxel-by-voxel Logan plots showed bilateral reduced [(11)C]FMZ binding in the parahippocampal gyrus and right lateral superior temporal gyrus (p uncorrected < or =0.001). In the temporal area, [(11)C]FMZ binding showed a strong inverse correlation with HPA axis activity. Plasma GABA did not discriminate MDD from controls, but correlated inversely with [(11)C]FMZ binding in the right insula. Following treatment with citalopram, voxel-based analysis revealed reduced binding in the right lateral temporal gyrus and dorsolateral prefrontal cortex.
Conclusion: The bilateral reduction in limbic parahippocampal and right temporal [(11)C]FMZ binding found in MDD indicates decreased GABA(A)-benzodiazepine receptor complex affinity and/or number. The inverse relationship between GABA(A) binding in the temporal lobe and HPA axis activity, suggests that HPA axis hyperactivity is partly due to reduced GABA-ergic inhibition.
Similar articles
-
Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency.Neurology. 2009 Aug 11;73(6):423-9. doi: 10.1212/WNL.0b013e3181b163a5. Neurology. 2009. PMID: 19667317 Free PMC article.
-
Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI.Brain. 2002 Oct;125(Pt 10):2257-71. doi: 10.1093/brain/awf233. Brain. 2002. PMID: 12244083
-
Reduced binding potential of GABA-A/benzodiazepine receptors in individuals at ultra-high risk for psychosis: an [18F]-fluoroflumazenil positron emission tomography study.Schizophr Bull. 2014 May;40(3):548-57. doi: 10.1093/schbul/sbt052. Epub 2013 Apr 15. Schizophr Bull. 2014. PMID: 23588475 Free PMC article.
-
Positron emission tomography imaging of the γ-aminobutyric acid system.Neurosci Lett. 2019 Jan 19;691:35-43. doi: 10.1016/j.neulet.2018.08.010. Epub 2018 Aug 10. Neurosci Lett. 2019. PMID: 30102960 Review.
-
Ethyl 8-fluoro-5-[11C]methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate.2008 Apr 28 [updated 2008 Jun 10]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Apr 28 [updated 2008 Jun 10]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641752 Free Books & Documents. Review.
Cited by
-
The utility of PET imaging in depression.Front Psychiatry. 2024 Apr 22;15:1322118. doi: 10.3389/fpsyt.2024.1322118. eCollection 2024. Front Psychiatry. 2024. PMID: 38711875 Free PMC article. Review.
-
GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy: A Positron Emission Tomography and Transcranial Magnetic Stimulation Study.Neuropsychobiology. 2024;83(1):17-27. doi: 10.1159/000535512. Epub 2023 Dec 27. Neuropsychobiology. 2024. PMID: 38151012 Free PMC article.
-
Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression.Pharmaceuticals (Basel). 2023 Nov 7;16(11):1572. doi: 10.3390/ph16111572. Pharmaceuticals (Basel). 2023. PMID: 38004437 Free PMC article. Review.
-
GABAA receptor availability relates to emotion-induced BOLD responses in the medial prefrontal cortex: simultaneous fMRI/PET with [11C]flumazenil.Front Neurosci. 2023 Sep 12;17:1027697. doi: 10.3389/fnins.2023.1027697. eCollection 2023. Front Neurosci. 2023. PMID: 37766785 Free PMC article.
-
Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future.Neuropsychopharmacology. 2024 Jan;49(1):83-95. doi: 10.1038/s41386-023-01728-8. Epub 2023 Sep 14. Neuropsychopharmacology. 2024. PMID: 37709943 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical